Viewing Study NCT04930757


Ignite Creation Date: 2025-12-24 @ 6:44 PM
Ignite Modification Date: 2025-12-26 @ 6:51 PM
Study NCT ID: NCT04930757
Status: UNKNOWN
Last Update Posted: 2021-06-18
First Post: 2021-05-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Involvement of Polymorphonuclear Neutrophils and Platelets in Severe Form of COVID-19
Sponsor: Assistance Publique - Hôpitaux de Paris
Organization:

Study Overview

Official Title: Involvement of Polymorphonuclear Neutrophils and Platelets in Severe Form of COVID-19
Status: UNKNOWN
Status Verified Date: 2021-06
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: NeutroVID
Brief Summary: The main objective is to quantify the population of reverse migrating neutrophils in patients with COVID-19.
Detailed Description: This is a non-interventional transversal research whose main objective is to quantify the population of reverse migrating neutrophils in patients with COVID-19.

Design:

A multicentric (3 sites) clinical trial

Sample size :

200 patients

Population concerned:

Patients hospitalized in intensive care with SARS-CoV-2 infection confirmed by RT-PCR from a nasopharyngeal swab.

Duration of participation (treatment + follow-up): until the patient is discharged from the ICU and within 2 months top.

No interim analysis is planned. Analysis will be performed at the end of the study.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: